The Weight Management Segment to Dominate Europe Therapeutic Dog Food Market during 2021-2028

According to a new market research study on “Europe therapeutic dog food market to 2028 – COVID-19 Impact and Regional Analysis and Forecast – by Product Type, Application and Country,” is expected to reach US$ 2,854.83 million by 2028 from US$ 1,920.56 million in 2021. The market is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The report provides trends prevailing in the Europe therapeutic dog food market along with the drivers and restraints pertaining to the market growth. Rise in the adoption of dogs for companionship, dogs becoming more prone to chronic diseases among dogs and increments in the launch of novel therapeutic dog food products are major factors driving the growth of the Europe therapeutic dog food market. However, drop down in sales in developing countries may hinder the growth of Europe therapeutic dog food market.

The countries in Europe are highly affected due to the COVID-19 pandemic. Italy and Spain have registered the maximum number of deaths due to COVIID-19. However, the animal health industry in European countries is minimally affected. The rapid increase in pet care spending in developed markets, such as the UK, Germany, and France, has also been accompanied by a surge in demand from newer and dynamic markets. In many countries, millennials are increasingly seeing pets as an alternative to children, driving pet adoption. As the COVID-19 crisis unfolds, the increase in pet care spending will change. At present, the short-term effects of the pandemic have been mixed, and many veterinary practices have remained closed for weeks due to containment measures. Also, the closure of adoption centers in a few countries slowed the pet ownership for some time in 2021. However, the market has not witnessed a sharp decline in the growth as many countries in the region have seen a rise in pet adoption after a few months.

The market for Europe therapeutic dog food is segmented into product type, application and country. Based on product type, the market is segmented into dry food, wet/canned food, snacks/treats, and others. In 2021, the dry food segment held the largest share in Europe therapeutic dog food market. Based on application, the Europe therapeutic dog food market is divided into weight management, digestive care, allergy and immune system health, and others. The digestive care segment is expected to be the fastest growing segment over the forecast period. Based on country, the Europe therapeutic dog food market is segmented into UK, Germany, France, Italy, Spain and rest of Europe. In 2021, Germany held the largest share in Europe therapeutic dog food market. Furthermore, in this present scenario of COVID 19 pandemic, the Europe therapeutic dog food market has been facing difficulties and several countries have suffered heavily. The manufacturing sectors in the Europe countries have been experiencing low production and a weak supply chain. Thereby, impacting the market for therapeutic dog food.

Mars Incorporated; Nestlé.; Hill's Pet Nutrition, Inc; Blue Buffalo Co., Ltd. (General Mills, Inc.); Animonda; Affinity Petcare S.A.; Beaphar; and WellPet are some of the leading companies in the Europe therapeutic dog food market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com